The impact of clinical trials on the treatment of lung cancer

This publication has 9 references indexed in Scilit:

• Audit: The use of radiotherapy for NSCLC in the UK
  Clinical Oncology, 1993
• A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status
  British Journal of Cancer, 1992
• A prospective study of low dose oral etoposide in poor prognosis small cell lung cancer (SCLC): A J Dorward for the West of Scotland Lung Cancer Group
  Lung Cancer, 1991
• Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions
  British Journal of Cancer, 1991
• The Royal College of Radiologists' fractionation survey
  Clinical Oncology, 1989
• Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer
  British Journal of Cancer, 1989
• Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer: Report to the medical research council by its lung cancer working party
  Respiratory Medicine, 1989
• The influence of clinical trials in the treatment of cancer: results of a survey
  The British Journal of Radiology, 1985
• RANDOMISED COMPARATIVE STUDIES IN THE TREATMENT OF CANCER IN THE UNITED KINGDOM: ROOM FOR IMPROVEMENT?
  The Lancet, 1979